160.10 +0.79 (0.50%)
After hours: 4:26PM EDT
|Bid||159.13 x 1100|
|Ask||160.14 x 900|
|Day's Range||158.96 - 161.96|
|52 Week Range||81.79 - 169.14|
|Beta (5Y Monthly)||1.33|
|PE Ratio (TTM)||238.13|
|Earnings Date||Oct. 28, 2020 - Nov. 02, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||184.17|
IQVIA™ (NYSE: IQV) today announced that Nancy Dreyer, chief scientific officer and senior vice president, Real World Solutions, has been awarded PharmaVOICE magazine’s Red Jacket honor after she was recognized multiple times as a PharmaVOICE 100. IQVIA’s Deepa Desai, vice president and head, Quality Management Systems, Quality Assurance, was honored on the 2020 PharmaVOICE 100 List, which identifies the most influential and inspiring leaders within the life sciences industry.
The vast majority of patients in the United States are experiencing lower out-of-pocket costs for their drugs, paying a smaller share of costs and seeing a downward trend in their costs on average. That’s according to the latest report from The IQVIA™ Institute for Human Data Science, Medicine Spending and Affordability in the U.S.: Understanding Patient Costs for Medicines. The improved affordability for patients is due to changes in health insurance benefit design, a higher use of generics, record low price increases on branded drugs and more patients reaching "catastrophic" coverage levels.
IQV vs. SSTI: Which Stock Is the Better Value Option?